Abstract
The SENTRY Antimicrobial Surveillance Program was established to monitor the occurrence and antimicrobial susceptibility of bacterial pathogens via an international network of sentinel hospitals. Twenty European hospitals referred a total of 887 urinary tract infection (UTI) isolates to the European SENTRY reference laboratory during the period October–December 1997. Ninety percent of the referred species were represented by Escherichia coli (52%), Enterococcus spp. (12%), Klebsiella spp. (7%), Proteus spp. (7%), Pseudomonas aeruginosa (7%), and Enterobacter spp. (5%). The susceptibility of E. coli isolates to penicillins was less than 60%, while almost all of the isolates were susceptible to piperacillin/tazobactam (98% susceptibility), cephalosporins (98%), and carbapenems (100%). Amikacin was the best aminoglycoside (99.8% susceptibility). The susceptibility to quinolones was only 88–89%, with highest levels of resistance observed for isolates from Portugal, Italy, England, The Netherlands, and some centers in France, Spain, and Poland. The susceptibility of Klebsiella spp. to the newer generations of cephalosporins was 82–95% and to the carbapenems 100%. Amikacin was again the best aminoglycoside (94% susceptibility). The susceptibility of Enterobacter spp. to any ß-lactam antibiotic was poor, except for the carbapenems (100% susceptibility) and cefepime (90% susceptibility), while the susceptibility to aminoglycosides was 80–89%. Proteus spp. showed complete susceptibility to cefepime, ceftriaxone, the carbapenems, and piperacillin/tazobactam, while the susceptibility of P. aeruginosa isolates was poor, with best results for the carbapenems (susceptibility 89%), piperacillin/tazobactam (susceptibility 84%), and amikacin and ticarcillin (susceptibility to both 80%). Enterococcus spp. showed the highest susceptibility to vancomycin (98%), teicoplanin (98%), and ampicillin (94%).
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ayliffe GAJ (1997) The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin. Infect. Dis. 24 (Suppl. 1): S74-S79.
Baquero F (1996) Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. J. Antimicrob. Chemother. 38 (Suppl. A): 117–132.
Cohen ML (1992) Epidemiology of drug resistance; implications for a post antimicrobial era. Science 257: 1050–1055.
Cornaglia G, Ligozzi M, Mazzariol A, Valentini M, Orefici G & Fontana R (1996) Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy, 1993–1995. Emerg. Infect. Dis. 2: 339–342.
Gold SG & Moellering RC (1996) Antimicrobial drug resistance. New Engl. J. Med. 335: 1445–1453.
Grüneberg RN (1994) Changes in urinary pathogens and their antibiotic sensitivities, 1971–1992. J. Antimicrob. Chemother. 33 (Suppl. A): 1–8.
Johnson JR & Stamm WE. (1989) Urinary tract infections in women: diagnosis and treatment. Ann. Intern. Med. 111: 906–917.
Jones RN (1996) Impact of changing pathogens and antimicrobial susceptibility patterns in the treatment of serious infections in hospitalized patients. Am. J. Med. 100 (Suppl. 6A): 3S-12S.
Leqclerc R (1997) Enterococci acquire new kinds of resistance. Clin. Infect. Dis. 24 (Suppl. 1): S80-S84.
Marco CA & Parker K (1997) Antimicrobial resistance among organisms causing urinary tract infections. Acad. Emerg. Med. 4:159–160.
Morrison AM & Wenzel RP (1986) Nosocomial urinary tract infections due to Enterococcus. Arch. Intern. Med. 146: 1549–1551.
Naber KG, Witte W, Bauernfeind A, Wiedemann B. Wagenlehener F, Klare I & Heisig P (1994) Clinical significance and spread of fluoroquinilone resistant uropathogens in hospitalised urological patients. Infection 22 (Suppl. 2): S122-S127.
National Committee for Clinical Laboratory Standards (1998) Performance standards for antimicrobial susceptibility testing. Supplement tables, M100-S8. Wayne, PA: NCCLS.
O'Brien TF & Stelling JM (1996) WHONET: removing obstacles to the full use of information about antimicrobial resistance. Diagn. Microbiol. Infect. Dis. 25: 162–168.
Rahal K, Wang F, Schindler J, Rowe B, Cookson B, Huovinen P, Marton A, Lalitha MK, Semina N, Kronvall G & Guzman M (1997) Reports on surveillance of antimicrobial remittance in individual countries. Clin. Infect. Dis. 24 (Suppl. 1): S169-S175.
Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ & the Pneumococcal Surveillance Working Group (1991) Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979–1987. J. Infect. Dis. 163: 1273–1278.
Struelens MJ & Mertens MR (1994) National survey of methicillinresistant Staphylococcus aureus in Belgian hospitals: detection methods, prevalence trends and infection control measures. Eur. J. Clin. Microbiol. Infect. Dis. 13: 56–63.
Warren JW (1997) Catheter-associated urinary tract infections. Infect. Dis. Clin. N. Am. 11: 609–622.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fluit, A.C., Jones, M.E., Schmitz, FJ. et al. Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997. Antonie Van Leeuwenhoek 77, 147–152 (2000). https://doi.org/10.1023/A:1002003123629
Issue Date:
DOI: https://doi.org/10.1023/A:1002003123629